Skip to content

Jumping Exercises Approach in Individuals With Chronic Ankle Instability

The Effect of a 12-week Training Jumping Exercises Program in Individuals With Chronic Ankle Instability: Randomized Controlled Trial Pilot Study

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02115971
Enrollment
10
Registered
2014-04-16
Start date
2013-09-30
Completion date
2015-08-31
Last updated
2016-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Joint Instability, Chronic Disease, Sprains

Keywords

chronic, functional, instability, ankle

Brief summary

The aim of this pilot study is to analyze the effect of a 12-week specific jump training compared with conventional therapy in patients with chronic functional instability of the ankle. It is to be evaluated to what extent the symptoms in of chronic functional instability of the ankle can be influenced in everyday life.

Detailed description

There is a need for; 1. more homogeneous sub- groups with chronic functional instability of the ankle. 2. Studies are needed that older patients (up to 50 years) and also take into account women. 3. In addition, studies should be performed in a clinical environment and also at the same time clinically adapted test can be used as a form measurement. ( Hiller et al. , 2011).

Interventions

Total 120min exercise

Total 120 min exercise

Sponsors

Swanenburg
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* Ankle injury more than 6 months ago * Chronic instability * Functional instability of the ankle * Experience with proprioceptive exercises

Exclusion criteria

* Foot surgery * Fresh ankle injury * Acute foot pain with signs of inflammation * Mechanical / anatomical ankle instability * Athletes with regularly jumping exercise (eg volleyball, basketball) * Taking medications which affect balance and coordination * Diseases that affect the balance * Serious diseases such as tumors, infections, neuropathies, severe articular degeneration * Non-German-speaking patients

Design outcomes

Primary

MeasureTime frameDescription
Change from Baseline in Gait variablesChange from Baseline in Gait variables at week 3, week 7, and at the end of therapy (week 12)Gait variables will be assessed with the OptoGait system OptoGait system is a floor-based photocell system for measuring spatiotemporal gait parameters. All measurements will be executed within 1hour

Secondary

MeasureTime frameDescription
BalanceBaseline, week 3, week 7, and at the end of therapy (week 12)Time to Stability (Forceplate Accusway AMTI) * 1 leg jump test * step down test
Health questionnaireBaseline, week 3, week 7, and at the end of therapy (week 12), followup 12 monthsEQ-5D is a standardised instrument for use as a measure of health outcome.
Foot function questionnaireBaseline, week 3, week 7, and at the end of therapy (week 12)The Foot and Ankle Ability Measure (FAAM) is a self-report outcome instrument developed to assess physical function for individuals with foot and ankle related impairments.
Personal calendar12 monthsParticipant could enter any new ankle sprain into this calendar. As soon as possible after new ankle sprain the participant had to fill in the date, its cause, and sprain-related injuries. The calendar pages contained questions about the circumstances surrounding the new ankle sprain, including how and where it happened, activity performed, possible injury symptoms, time to recover and whether medical assistance or physical therapy was needed. Participants are also requested to record direct medical costs (e.g. physiotherapy, visits to general practitioners and medical specialists, nursing care, and medication) and indirect cost (e.g. disability related loss) using the personal calendar. At the end of 2 month, a calendar page was sent by each patient to the investigators

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026